Biofrontera Inc.

Biofrontera is headquartered in the United States and generates revenue through its U.S. commercial organization. The company’s disclosed business model centers on direct sales to domestic dermatology practices, so the U.S. is the key market for both revenue and operating execution. Its product and regulatory support structure also depends on Biofrontera AG and related entities outside the U.S., particularly for regulatory and pharmacovigilance support. Because the company is small and cash constrained, geography matters mainly through U.S. commercial penetration and the ability to maintain cross-border support arrangements efficiently.